Frontage Laboratories Acquires Concord Biosciences

Frontage Laboratories Completes Acquisition of Teddy Clinical Research Laboratory (Shanghai)

March 4, 2026

Healthcare Services

Frontage Laboratories, Inc. completed its acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd. to expand Frontage’s global central laboratory capabilities and strengthen its footprint in China and the Asia-Pacific region. Teddy Lab will be integrated into Frontage’s “one-stop shop” CRO/CDMO service platform to support growing demand for domestic and multi-regional clinical trials.

Discovery Life Sciences Acquires ReachBio Research Labs

April 11, 2023

Biotechnology

Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.

Clinical Reference Laboratory Acquires Confirm BioSciences

December 9, 2020

Healthcare Services

Clinical Reference Laboratory (CRL), a large privately held clinical testing laboratory, has acquired Confirm BioSciences, a San Diego–based provider of screening tools and consumer-facing testing products. The acquisition will have Confirm operate as a subsidiary and is intended to expand CRL's lab testing and R&D capabilities while leveraging Confirm's large retail/customer base and COVID-19 testing pipeline.

Eurofins Discovery Acquires DiscoveryBioMed

July 5, 2022

Biotechnology

Eurofins Discovery has acquired DiscoveryBioMed, a Birmingham, Alabama–based contract research organization specializing in human primary- and immortalized-cell based bioassays. The acquisition strengthens Eurofins Discovery’s translational biology and human cell assay capabilities to expand its drug discovery services portfolio.

Charles River Laboratories Acquires Explora BioLabs

April 6, 2022

Biotechnology

Charles River Laboratories has acquired Explora BioLabs Holdings, a San Diego–based provider of contract vivarium services, for approximately $295 million in cash. The deal expands Charles River’s CRADL footprint with more than 15 additional vivarium facilities (bringing expected combined capacity to at least 25 sites and ~300,000 sq ft by end of 2022) and adds complementary preclinical vivarium management capabilities and clients.

eMolecules Acquires Frontier Scientific Inc. and Frontier Agricultural Sciences Inc.

September 7, 2022

Pharmaceuticals

eMolecules, a PE-backed provider of a chemistry search-and-fulfillment platform, has acquired Frontier Scientific Inc. (FSI) and Frontier Agricultural Sciences Inc. (FAS). The acquisitions expand eMolecules' capabilities in compound/sample management, analytical and procurement services and provide an entry into agricultural chemistry/entomology research markets.